Compositions and Methods for Inhibition of Cathepsins
申请人:OXIGENE, INC.
公开号:US20130296605A1
公开(公告)日:2013-11-07
This invention is directed to compound of Formula I and methods of using these compounds in the treatment of conditions in which modulation of a cathepsin, particularly cathepsin K or cathepsin L, will be therapeutically useful.